Background: Since it was described in 1980, percutaneous endoscopic gastrostomy (PEG) has been a widely used method for insertion of a gastrostomy tube in patients who are unable to swallow or ...

Gastroesophageal reflux (GER) is a common problem in mechanically ventilated patients and contributes to the development of esophageal mucosal injury and even erosive esophagitis. The relationship ...

Phase II study of dichloroacetate (DCA) in combination with chemoradiation (CRT) for unresected, locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN). Retrospective analysis of ...

In November 2001, a 29-year-old woman was admitted to the hospital because of dysphagia due to an apallic state caused by cerebral anoxia. Nutritional support was maintained by nasogastric tube ...

Percutaneous endoscopic gastrostomy (PEG) is a method commonly used for providing long-term nutrition for patients unable to swallow but with a functioning gastrointestinal tract (Stefan et al, 1989).

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window CHICAGO -- ...

Percutaneous endoscopic gastrostomy (PEG) is a common procedure that provides enteral access for the administration of tube feeding in patients who are unable to obtain adequate nutrition by mouth.

The Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for Tiglutik (riluzole; ITF Pharma) oral suspension to include administration via percutaneous ...

Scientists have known that impairment of oral intake occurs in the majority of patients with head and neck cancer (HNC) receiving chemoradiotherapy. Placement of prophylactic percutaneous endoscopic ...

Percutaneous endoscopic gastrostomy (PEG) has become the primary procedure for long-term enteral nutrition of most, but not all patients with dysphagia. Still in some patients gastrostomy may only be ...

Advanced Radiation Therapy Technology Use in the Treatment of Bone Metastases in a Public, Salary-Funded, Non-Incentivized Health Care System Demographics, clinical variables, and patient outcomes ...